FDA Approves Akeega for BRCA-Positive Metastatic Prostate Cancer
Akeega plus prednisone significantly improves radiographic progression-free survival in patients with castration-resistant prostate cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.